Vetacalm en es it fr

Vetacalm Brand names, Vetacalm Analogs

Vetacalm Brand Names Mixture

  • No information avaliable

Vetacalm Chemical_Formula

C18H18ClNS

Vetacalm RX_link

No information avaliable

Vetacalm fda sheet

Vetacalm msds (material safety sheet)

Vetacalm MSDS

Vetacalm Synthesis Reference

No information avaliable

Vetacalm Molecular Weight

315.861 g/mol

Vetacalm Melting Point

97.5 oC

Vetacalm H2O Solubility

0.295 mg/L

Vetacalm State

Solid

Vetacalm LogP

5.654

Vetacalm Dosage Forms

Tablets; Syrup (concentrate)

Vetacalm Indication

For treatment of psychotic disorders (e.g. schizophrenia) and of acute mania occuring as part of bipolar disorders.

Vetacalm Pharmacology

Chlorprothixene is a typical antipsychotic drug of the thioxanthine class. It has a low antipsychotic potency (half to 2/3 of chlorpromazine). An intrinsic antidepressant effect of chlorprothixene has been discussed, but not proven yet. Likewise, it is unclear, if chlorprothixene has genuine analgesic effects. An antiemetic effect, as with most antipsychotics, exists. It is used in the treatment of nervous, mental, and emotional conditions. Improvement in such conditions is thought to result from the effect of the medicine on nerve pathways in specific areas of the brain. Chlorprothixene has a strong sedative activity with a high incidence of anticholinergic side-effects. Chlorprothixene is structurally related to chlorpromazine, with which it shares in principal all side effects. Allergic side-effects and liver damage seem to appear with an appreciable lower frequency.

Vetacalm Absorption

No information avaliable

Vetacalm side effects and Toxicity

Symptoms of overdose include difficulty in breathing (severe), dizziness (severe), drowsiness (severe), muscle trembling, jerking, stiffness, or uncontrolled movements (severe), small pupils, unusual excitement, and unusual tiredness or weakness (severe).

Vetacalm Patient Information

Vetacalm Organisms Affected

Humans and other mammals